Renamed to Elevance Health (NYSE:ELV) in August 2022
ANTM - Anthem, Inc.
NYSE
->
Healthcare
->
Healthcare Plans
Indianapolis,
United States
Type: Equity
ANTM price evolution
ANTM
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6161 | $4880 | $5490 | $5258 |
| Short term investments | $27881 | $28148 | $28467 | $27594 |
| Net receivables | $14662 | $13440 | $12807 | $12685 |
| Inventory | ||||
| Total current assets | $53897 | $51122 | $51904 | $50238 |
| Long term investments | $5961 | $5857 | $5584 | $5498 |
| Property, plant & equipment | $3986 | $3919 | $3835 | $3733 |
| Goodwill & intangible assets | $34839 | $34843 | $34933 | $34939 |
| Total noncurrent assets | $46589 | $46338 | $46156 | $45859 |
| Total investments | $33842 | $34005 | $34051 | $33092 |
| Total assets | $100486 | $97460 | $98060 | $96097 |
| Current liabilities | ||||
| Accounts payable | $20206 | $18488 | $19522 | $18674 |
| Deferred revenue | $1210 | $1153 | $954 | $1081 |
| Short long term debt | $3372 | $1874 | $1024 | $1024 |
| Total current liabilities | $39733 | $34885 | $35162 | $33794 |
| Long term debt | $19883 | $21157 | $21761 | $22217 |
| Total noncurrent liabilities | $24722 | $26447 | $27090 | $27257 |
| Total debt | $23255 | $23031 | $22785 | $23241 |
| Total liabilities | $64455 | $61332 | $62252 | $61051 |
| Shareholders' equity | ||||
| Retained earnings | $28058 | $27088 | $26700 | $25874 |
| Other shareholder equity | -$1236 | -$178 | -$103 | -$17 |
| Total shareholder equity | $35975 | $36060 | $35737 | $34968 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4880 | $5741 | $4937 | $3934 |
| Short term investments | $28148 | $24992 | $20698 | $18206 |
| Net receivables | $13440 | $10958 | $10218 | $9301 |
| Inventory | ||||
| Total current assets | $51122 | $45751 | $39033 | $34321 |
| Long term investments | $5857 | $4847 | $4763 | $4246 |
| Property, plant & equipment | $3919 | $3483 | $3133 | $2735 |
| Goodwill & intangible assets | $34843 | $31096 | $29174 | $29511 |
| Total noncurrent assets | $46338 | $40864 | $38420 | $37250 |
| Total investments | $34005 | $29839 | $25461 | $22452 |
| Total assets | $97460 | $86615 | $77453 | $71571 |
| Current liabilities | ||||
| Accounts payable | $18488 | $16852 | $13475 | $13214 |
| Deferred revenue | $1153 | $1259 | $1017 | $902 |
| Short long term debt | $1874 | $700 | $2298 | $1994 |
| Total current liabilities | $34885 | $29453 | $23617 | $21965 |
| Long term debt | $21157 | $19335 | $17787 | $17217 |
| Total noncurrent liabilities | $26447 | $23963 | $22108 | $21065 |
| Total debt | $23031 | $20035 | $20085 | $19211 |
| Total liabilities | $61332 | $53416 | $45725 | $43030 |
| Shareholders' equity | ||||
| Retained earnings | $27088 | $23802 | $22573 | $19988 |
| Other shareholder equity | -$178 | $150 | -$296 | -$986 |
| Total shareholder equity | $36060 | $33199 | $31728 | $28541 |
| (in millions $) | 31 Mar 2022 | 31 Jan 2022 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $38095 | $35822 | $33851 | |
| Cost of revenue | $31098 | $29543 | $27377 | |
| Gross Profit | $6997 | $6279 | $6474 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4341 | $3946 | $3821 | |
| Total operating expenses | $4470 | $4082 | $3911 | |
| Operating income | $2527 | $2197 | $2563 | |
| Income from continuing operations | ||||
| EBIT | $2537 | $2204 | $2550 | |
| Income tax expense | $531 | $494 | $552 | |
| Interest expense | $201 | $201 | $205 | |
| Net income | ||||
| Net income | $1805 | $1509 | $1793 | |
| Income (for common shares) | $1805 | $1509 | $1793 | |
| (in millions $) | 31 Jan 2022 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $121867 | $104213 | $92105 | |
| Cost of revenue | $96998 | $83778 | $71895 | |
| Gross Profit | $24869 | $20435 | $20210 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $17450 | $13364 | $14020 | |
| Total operating expenses | $17811 | $13702 | $14378 | |
| Operating income | $7058 | $6733 | $5832 | |
| Income from continuing operations | ||||
| EBIT | $7022 | $6731 | $5821 | |
| Income tax expense | $1666 | $1178 | $1318 | |
| Interest expense | $784 | $746 | $753 | |
| Net income | ||||
| Net income | $4572 | $4807 | $3750 | |
| Income (for common shares) | $4572 | $4807 | $3750 | |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Net income | $1805 | $1137 | $1509 | $1793 |
| Operating activities | ||||
| Depreciation | $358 | $360 | $351 | $309 |
| Business acquisitions & disposals | -$61 | -$34 | -$3415 | |
| Stock-based compensation | $50 | $59 | $63 | $69 |
| Total cash flows from operations | $2541 | $1672 | $2504 | $1683 |
| Investing activities | ||||
| Capital expenditures | -$254 | -$340 | -$258 | -$285 |
| Investments | -$794 | -$653 | -$773 | -$1300 |
| Total cash flows from investing | -$1578 | -$966 | -$1440 | -$4925 |
| Financing activities | ||||
| Dividends paid | -$309 | -$273 | -$276 | -$278 |
| Sale and purchase of stock | -$469 | -$480 | -$431 | -$428 |
| Net borrowings | $211 | $186 | -$452 | -$227 |
| Total cash flows from financing | $322 | -$1315 | -$830 | -$820 |
| Effect of exchange rate | -$4 | -$1 | -$2 | -$6 |
| Change in cash and equivalents | $1281 | -$610 | $232 | -$4068 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $6104 | $4572 | $4807 | $3750 |
| Operating activities | ||||
| Depreciation | $1302 | $1154 | $1133 | $1132 |
| Business acquisitions & disposals | -$3476 | -$1976 | -$1760 | |
| Stock-based compensation | $255 | $283 | $294 | $226 |
| Total cash flows from operations | $8364 | $10688 | $6061 | $3827 |
| Investing activities | ||||
| Capital expenditures | -$1087 | -$1021 | -$1077 | -$1208 |
| Investments | -$4056 | -$3433 | -$1277 | $2460 |
| Total cash flows from investing | -$9638 | -$7324 | -$2792 | -$1259 |
| Financing activities | ||||
| Dividends paid | -$1104 | -$954 | -$818 | -$776 |
| Sale and purchase of stock | -$1697 | -$2524 | -$1514 | -$262 |
| Net borrowings | $2719 | -$298 | $439 | -$1296 |
| Total cash flows from financing | $423 | -$2567 | -$2266 | -$2241 |
| Effect of exchange rate | -$10 | $7 | -$2 | |
| Change in cash and equivalents | -$861 | $804 | $1003 | $325 |
News
|
Baillie Gifford’s 13F Portfolio - Q2 2022 Update
Seeking Alpha
10 Aug 2022
|
|
Governor announces additional key administration appointments
Augusta Free Press
4 Aug 2022
|
|
Obituaries in Phoenix, AZ | The Arizona Republic
The Arizona Republic
4 Aug 2022
|
|
Tinder's first female CEO out after less than a year – KION546
KION 46 Salinas
3 Aug 2022
|
|
Senseonics poised to get diabetes device to more patients after big insurer expands coverage
American City Business Journals
3 Aug 2022
|
|
Tinder's first female CEO out after less than a year - KVIA
ABC 7 El Paso
3 Aug 2022
|
|
James Dallas to step down as chairman of Centene Corp. board of directors - St. Louis Business...
The Business Journals
2 Aug 2022
|
|
Elevance Health Raises Annual Profit Guidance
Benzinga via Yahoo Finance
20 Jul 2022
|
|
Elevance Health stock drops to lead S&P 500 losers as earnings 'beat and raise' missed high...
MarketWatch
20 Jul 2022
|
|
Anthem (ELV) Surpasses Q2 Earnings and Revenue Estimates
Zacks via Yahoo Finance
20 Jul 2022
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 241.14M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 17.63% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 154.31 |
| Cash/Share | 25.55 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.70 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.36 |
| Quick ratio | 1.36 |